Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.82. Operator: Good morning, ladies and gentlemen. Thank ...

As the Canadian economy experiences a cooling labor market and anticipates further interest rate cuts by the Bank of Canada, financial markets are poised to navigate these shifts with cautious ...

This also supported additional principal payments on our debt agreement, continuing to improve the Company's balance sheet.” McCarthy added ... third parties to process and transmit claims to payers ...

The medical device industry faces unique challenges as PFAS begins to face regulation in the U.S. and Europe despite ...